LPNT
Income statement / Annual
Last year (2017), LifePoint Health, Inc.'s total revenue was $7.26 B,
a decrease of 0.14% from the previous year.
In 2017, LifePoint Health, Inc.'s net income was $102.40 M.
See LifePoint Health, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
FY-2010
|
FY-2009
|
FY-2008
|
| Period Ended |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
12/31/2011 |
12/31/2010 |
12/31/2009 |
12/31/2008 |
| Operating Revenue |
$7.26 B |
$7.27 B |
$6.01 B |
$5.30 B |
$4.43 B |
$4.02 B |
$3.03 B |
$3.26 B |
$2.96 B |
$2.70 B |
| Cost of Revenue |
$4.11 B
|
$4.11 B
|
$3.31 B
|
$2.83 B
|
$2.30 B
|
$2.08 B
|
$1.83 B
|
$1.71 B
|
$1.58 B
|
$1.44 B
|
| Gross Profit |
$3.15 B
|
$3.16 B
|
$2.70 B
|
$2.47 B
|
$2.12 B
|
$1.94 B
|
$1.19 B
|
$1.55 B
|
$1.38 B
|
$1.26 B
|
| Gross Profit Ratio |
0.43
|
0.43
|
0.45
|
0.47
|
0.48
|
0.48
|
0.39
|
0.47
|
0.47
|
0.47
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$520.00 M
|
$552.60 M
|
$423.20 M
|
$367.70 M
|
$316.20 M
|
$280.30 M
|
$514.80 M
|
$458.90 M
|
$430.50 M
|
$399.90 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$520.00 M
|
$552.60 M
|
$423.20 M
|
$367.70 M
|
$316.20 M
|
$280.30 M
|
$514.80 M
|
$458.90 M
|
$430.50 M
|
$399.90 M
|
| Other Expenses |
$2.31 B
|
$2.23 B
|
$1.85 B
|
$1.72 B
|
$1.50 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$2.83 B
|
$2.78 B
|
$2.28 B
|
$2.08 B
|
$1.82 B
|
$1.58 B
|
$821.50 M
|
$1.20 B
|
$1.06 B
|
$945.10 M
|
| Cost And Expenses |
$6.95 B
|
$6.90 B
|
$5.59 B
|
$4.92 B
|
$4.12 B
|
$3.66 B
|
$2.66 B
|
$2.91 B
|
$2.64 B
|
$2.38 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$148.80 M
|
$171.20 M
|
$114.40 M
|
$123.00 M
|
$102.90 M
|
$100.00 M
|
$107.10 M
|
$108.10 M
|
$103.20 M
|
$88.00 M
|
| Depreciation & Amortization |
$350.60 M
|
$344.60 M
|
$279.00 M
|
$250.50 M
|
$228.20 M
|
$193.10 M
|
$185.60 M
|
$165.60 M
|
$156.60 M
|
$141.40 M
|
| EBITDA |
$668.30 M |
$723.00 M |
$719.50 M |
$691.90 M |
$531.40 M |
$554.00 M |
$556.00 M |
$517.20 M |
$482.90 M |
$455.70 M |
| EBITDA Ratio |
0.09
|
0.1
|
0.12
|
0.13
|
0.12
|
0.14
|
0.18
|
0.16
|
0.16
|
0.17
|
| Operating Income Ratio |
0.04
|
0.05
|
0.07
|
0.08
|
0.07
|
0.09
|
0.12
|
0.11
|
0.11
|
0.12
|
| Total Other Income/Expenses Net |
-$157.90 M
|
-$172.40 M
|
-$124.20 M
|
-$180.70 M
|
-$97.30 M
|
-$108.40 M
|
-$107.10 M
|
-$110.50 M
|
-$104.30 M
|
-$91.40 M
|
| Income Before Tax |
$159.80 M
|
$204.80 M
|
$302.50 M
|
$203.00 M
|
$211.50 M
|
$244.10 M
|
$263.30 M
|
$241.10 M
|
$222.00 M
|
$226.30 M
|
| Income Before Tax Ratio |
0.02
|
0.03
|
0.05
|
0.04
|
0.05
|
0.06
|
0.09
|
0.07
|
0.07
|
0.08
|
| Income Tax Expense |
$46.90 M
|
$73.00 M
|
$109.50 M
|
$68.10 M
|
$79.30 M
|
$88.50 M
|
$97.80 M
|
$82.40 M
|
$80.30 M
|
$88.10 M
|
| Net Income |
$102.40 M
|
$121.90 M
|
$181.90 M
|
$126.10 M
|
$128.20 M
|
$151.90 M
|
$162.90 M
|
$155.50 M
|
$134.10 M
|
$114.50 M
|
| Net Income Ratio |
0.01
|
0.02
|
0.03
|
0.02
|
0.03
|
0.04
|
0.05
|
0.05
|
0.05
|
0.04
|
| EPS |
2.57 |
2.9 |
4.14 |
2.81 |
2.77 |
3.22 |
3.3 |
2.98 |
2.54 |
2.18 |
| EPS Diluted |
2.51 |
2.82 |
3.95 |
2.69 |
2.69 |
3.14 |
3.22 |
2.91 |
2.49 |
2.14 |
| Weighted Average Shares Out |
$39.90 M
|
$42.00 M
|
$43.90 M
|
$44.90 M
|
$46.30 M
|
$47.20 M
|
$49.30 M
|
$52.20 M
|
$52.70 M
|
$52.50 M
|
| Weighted Average Shares Out Diluted |
$40.80 M
|
$43.20 M
|
$46.10 M
|
$46.90 M
|
$47.60 M
|
$48.40 M
|
$50.50 M
|
$53.50 M
|
$53.80 M
|
$53.50 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
